Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

被引：0
|
作者：
Stephen J. Nicholls
Rishi Puri
Kathy Wolski
Christie M. Ballantyne
Philip J. Barter
H. Bryan Brewer
John J. P. Kastelein
Bo Hu
Kiyoko Uno
Yu Kataoka
Jean-Paul R. Herrman
Bela Merkely
Marilyn Borgman
Steven E. Nissen
机构：
[1] South Australian Health and Medical Research Institute,Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research
[2] Cleveland Clinic,Section of Cardiovascular Research
[3] Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center,Department of Vascular Medicine, Academic Medical Center
[4] University of New South Wales,Department of Cardiology
[5] Medstar Research Institute,Heart and Vascular Center
[6] University of Medicine,undefined
[7] Onze Lieve Vrouwe Gasthuis,undefined
[8] Semmelweis University,undefined
来源：
American Journal of Cardiovascular Drugs | 2016年 / 16卷
关键词：
Atorvastatin; Rosuvastatin; Plaque Burden; Interactive Voice Response; Incremental Benefit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：55 / 65
页数：10
相关论文
共 50 条
  • [41] A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
    Pedrosa, Marcos
    Seyedkazemi, Star
    Francque, Sven
    Sanyal, Arun
    Rinella, Mary
    Charlton, Michael
    Loomba, Rohit
    Ratziu, Vlad
    Kochuparampil, Jossy
    Fischer, Laurent
    Vaidyanathan, Sujata
    Anstee, Quentin M.
    CONTEMPORARY CLINICAL TRIALS, 2020, 88
  • [42] Efficacy and safety of the oral JAK3/TEC inhibitor ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO Phase 2b/3 randomized, double-blind, placebo-controlled trial
    Hordinsky, Maria K.
    Hebert, Adelaide
    Gooderham, Melinda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB51 - AB51
  • [43] Responder Rates to Atogepant in Patients With Episodic Migraine: A Post Hoc Analysis of Results From a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, David W.
    Ailani, Jessica
    Goadsby, Peter J.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Li, Ye
    Szegedi, Armin
    CEPHALALGIA, 2019, 39 : 183 - 184
  • [44] Responder Rates to Atogepant in Patients with Episodic Migraine: A Post Hoc Analysis of Results from a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, D. W.
    Ailani, J.
    Goadsby, P. J.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Li, Y.
    Szegedi, A.
    HEADACHE, 2019, 59 : 79 - 80
  • [45] A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis
    Mehta, Gautam
    Rousell, Sam
    Burgess, Gary
    Morris, Mark
    Wright, Gavin
    McPherson, Stuart
    Frenette, Catherine
    Cave, Matthew
    Hagerty, David T.
    Spada, Alfred
    Jalan, Rajiv
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 224 - 234
  • [46] Results of a phase 2b multicenter randomized trial of larsucosterol for the treatment of severe alcohol-associated hepatitis (AHFIRM trial)
    Shiffman, Mitchell
    Ben Da
    Stein, Lance
    Moreno, Christophe
    Mehta, Ashwini
    Louvet, Alexandre
    Nicoll, Amanda
    Goel, Aparna
    Kwong, Allison
    Flamm, Steven
    Satapathy, Sanjaya
    Kuo, Alexander
    Pyrsopoulos, Nikolaos T.
    Ganger, Daniel
    Aloman, Costica
    Strasser, Simone
    Tse, Edmund
    Russo, Mark
    Rockey, Don
    Gray, Meagan
    Mitchell, Mack
    Thursz, Mark R.
    Krebs, William
    Scott, Deborah
    Blevins, Christina
    Brown, James
    Lin, Weiqi
    Sussman, Norman
    JOURNAL OF HEPATOLOGY, 2024, 80 : S8 - S9
  • [47] The Effect of Tenapanor on Global Endpoints in Patients with Constipation Predominant Irritable Bowel Syndrome: Results from a 12-Week, Double-Blind, Placebo-Controlled, Randomized Phase 2b Trial
    Chey, William D.
    Lembo, Anthony J.
    Rosenbaum, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S236 - S236
  • [48] A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF INTERLEUKIN-2 IN CHRONIC HEPATITIS-B
    CARRENO, V
    ARTILLO, S
    BARTOLOME, J
    PASTORE, G
    SANTANTONIO, T
    MILELLA, M
    FATTOVICH, G
    GIUSTINA, G
    ALBERTI, A
    CHANEAC, M
    HEPATOLOGY, 1993, 18 (04) : A225 - A225
  • [49] Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study of Ecopipam in Children and Adolescents with Tourette Syndrome
    Mahableshwarkar, A.
    Dubow, J.
    Cunniff, T.
    Wanaski, S.
    MOVEMENT DISORDERS, 2022, 37 : S415 - S415
  • [50] Letter by Romanens and Miserez regarding article, "Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, double-blind trial"
    Romanens, Michel J.
    Miserez, Andre R.
    CIRCULATION, 2006, 114 (12) : E506 - E506
12345